Researchers have launched an innovative AI-powered platform for diagnosing endocrine cancers with over 99% accuracy. This groundbreaking development, unveiled at ENDO 2025, aims to revolutionize cancer care by enhancing early detection and treatment precision. The chief mentor, Elangovan Krishnan, emphasizes that this technology democratizes access to cancer diagnostics, facilitating timely and affordable care globally, especially in under-resourced areas.
To create this advanced platform, researchers employed deep learning architectures—EfficientNets and ResNets—utilizing multimodal datasets from various diagnostic imaging sources. This approach ensures robust generalizability across diverse patient populations. The online platform allows healthcare professionals worldwide to access and validate the model, demonstrating its real-world applicability and rapid processing speed of under one second per image.
Ultimately, this AI innovation represents a transformative step in biomedical technology, promoting health equity and improving patient outcomes in endocrine cancer diagnostics. For more details, visit endocrine.org.
Source link